Stanley C Erck is President and CEO of NOVAVAX INC. Currently has a direct ownership of 36,492 shares of NVAX, which is worth approximately $317,480. The most recent transaction as insider was on Dec 14, 2022, when has been sold 2,320 shares (Common Stock) at a price of $17.23 per share, resulting in proceeds of $39,973. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.5K
0% 3M change
0% 12M change
Total Value Held $317,480

Stanley C Erck Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2022
SELL
Payment of exercise price or tax liability
$39,973 $17.23 p/Share
2,320 Reduced 5.98%
36,492 Common Stock
Dec 14 2022
BUY
Exercise of conversion of derivative security
-
6,966 Added 15.22%
38,812 Common Stock
Sep 26 2022
SELL
Payment of exercise price or tax liability
$41,137 $18.87 p/Share
2,180 Reduced 6.41%
31,846 Common Stock
Sep 26 2022
BUY
Exercise of conversion of derivative security
-
6,546 Added 16.13%
34,026 Common Stock
Dec 14 2021
SELL
Payment of exercise price or tax liability
$566,935 $168.43 p/Share
3,366 Reduced 10.91%
27,480 Common Stock
Dec 14 2021
BUY
Exercise of conversion of derivative security
-
6,967 Added 18.42%
30,846 Common Stock
Oct 04 2021
SELL
Open market or private sale
$7,518,631 $175.55 p/Share
42,829 Reduced 64.2%
23,879 Common Stock
Oct 04 2021
BUY
Exercise of conversion of derivative security
$1,169,232 $27.3 p/Share
42,829 Added 39.1%
66,708 Common Stock
Oct 01 2021
SELL
Open market or private sale
$8,654,870 $176.63 p/Share
49,000 Reduced 67.23%
23,879 Common Stock
Oct 01 2021
BUY
Exercise of conversion of derivative security
$1,337,700 $27.3 p/Share
49,000 Added 40.2%
72,879 Common Stock
Sep 26 2021
SELL
Payment of exercise price or tax liability
$784,682 $248.16 p/Share
3,162 Reduced 11.69%
23,879 Common Stock
Sep 26 2021
BUY
Exercise of conversion of derivative security
-
6,546 Added 19.49%
27,041 Common Stock
Jul 02 2021
SELL
Open market or private sale
$11,358,000 $216.1 p/Share
52,559 Reduced 71.95%
20,495 Common Stock
Jul 02 2021
BUY
Exercise of conversion of derivative security
$4,141,649 $78.8 p/Share
52,559 Added 41.84%
73,054 Common Stock
Jul 01 2021
SELL
Open market or private sale
$11,183,854 $212.54 p/Share
52,620 Reduced 71.97%
20,495 Common Stock
Jul 01 2021
BUY
Exercise of conversion of derivative security
$3,213,503 $61.07 p/Share
52,620 Added 41.85%
73,115 Common Stock
Nov 16 2020
SELL
Open market or private sale
$4,725,704 $90.33 p/Share
52,316 Reduced 71.85%
20,495 Common Stock
Nov 16 2020
BUY
Exercise of conversion of derivative security
$1,710,766 $32.7 p/Share
52,317 Added 41.81%
72,811 Common Stock
Oct 01 2020
SELL
Open market or private sale
$217 $108.56 p/Share
2 Reduced 0.01%
20,494 Common Stock
Sep 30 2020
SELL
Open market or private sale
$1,370,239 $112.03 p/Share
12,231 Reduced 37.37%
20,496 Common Stock
Sep 29 2020
SELL
Open market or private sale
$443,191 $107.78 p/Share
4,112 Reduced 11.16%
32,727 Common Stock
Sep 28 2020
SELL
Sale (or disposition) back to the issuer
$148,759 $111.18 p/Share
1,338 Reduced 1.79%
73,268 Common Stock
Sep 28 2020
SELL
Open market or private sale
$2,800,690 $112.05 p/Share
24,995 Reduced 40.42%
36,839 Common Stock
Sep 28 2020
SELL
Payment of exercise price or tax liability
$1,270,676 $111.18 p/Share
11,429 Reduced 15.6%
61,839 Common Stock
Sep 28 2020
BUY
Exercise of conversion of derivative security
$297,500 $5.95 p/Share
50,000 Added 40.13%
74,606 Common Stock

Also insider at

MXCT
MAXCYTE, INC. Healthcare
SCE

Stanley C Erck

President and CEO
Gaithersburg, MD

Track Institutional and Insider Activities on NVAX

Follow NOVAVAX INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVAX shares.

Notify only if

Insider Trading

Get notified when an Novavax Inc insider buys or sells NVAX shares.

Notify only if

News

Receive news related to NOVAVAX INC

Track Activities on NVAX